HeartSciences (HSCS) Non Operating Income (2021 - 2026)
HeartSciences (HSCS) posted quarterly Non Operating Income of -$214499.0 for Q2 2026, down 23.32% year-on-year from -$279747.9 in Q2 2025, and up 22.67% on a QoQ basis from -$277366.0 in Q4 2025.
HeartSciences (HSCS) Non Operating Income (2021 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported Non Operating Income for 6 consecutive years, with -$214499.0 the latest figure, recorded in Q2 2026.
- Quarterly Non Operating Income fell 23.32% year-over-year to -$214499.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$846671.0 (down 105.17% YoY) and the FY2026 annual result came in at -$729008.0, down 76.66% from the prior year.
- Non Operating Income grew to -$214499.0 in Q2 2026 per HSCS's latest filing, from -$277366.0 in the prior quarter.
- Over the last five years, Non Operating Income for HSCS reached as high as $33626.0 in Q2 2024 and fell as low as -$277366.0 in Q4 2025.
- A 5-year average of -$108217.9 and a median of -$118429.0 in 2024 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2024 — Non Operating Income surged 199.77% — and 2025, when it slumped 854.34%.
- Year by year, Non Operating Income stood at -$31606.0 in 2022, then tumbled by 464.56% to -$178435.0 in 2023, then jumped by 45.14% to -$97885.0 in 2024, then tumbled by 183.36% to -$277366.0 in 2025, then gained by 22.67% to -$214499.0 in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered -$214499.0, -$277366.0, and -$180875.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - | -214,499.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -214,499.00 |
| Oct 31, 2025 | -277,366.00 |
| Jul 31, 2025 | -180,875.00 |
| Apr 30, 2025 | -173,931.00 |
| Jan 31, 2025 | -164,820.00 |
| Oct 31, 2024 | -97,885.00 |
| Jul 31, 2024 | 23,978.00 |
| Apr 30, 2024 | 33,626.00 |
| Jan 31, 2024 | -118,429.00 |
| Oct 31, 2023 | -178,435.00 |
| Jul 31, 2023 | -36,200.00 |
| Apr 30, 2023 | -33,702.00 |
| Jan 31, 2023 | -32,812.00 |
| Oct 31, 2022 | -31,606.00 |
| Jul 31, 2022 | -143,206.00 |
| Apr 30, 2022 | -75,326.00 |
| Jan 31, 2022 | -138,216.00 |
| Oct 31, 2021 | -77,914.00 |
| Jul 31, 2021 | 172,595.00 |